Thanks, Jes. I'll spend a couple of minutes summarizing the financial highlights for the full-year and then focus on the Q4 performance across the businesses. We have as usual highlighted notable items, and I'm pleased to say that we haven’t adjusted for anything material in Q4, although we have called out the additional $395 million additional compensation charges that Jes referred to earlier. When I run through performance of the businesses, I'll talk on an underlying basis, excluding notable items. Full year core RoTE it’s below double-digit at 9.4%, but that figure does include the additional compensation charge and reflects a significant increase in equity allocated to the core. The core businesses are showing great resilience in the year of significant political and macroeconomic events, with Barclays UK reporting an RoTE of 19.3% and Barclays International 8%. Our CET1 ratio strengthened significantly to 12.4%., up 80 basis points in Q4 making an increase of 100 basis points for the year. It is strong evidence of our organic capital generation and underpins our confidence in reaching end state capital levels. We've announced that we are closing non-core unit ahead of plan at the 30th of June with RWA is expected to be around $25 billion and also its reducing significantly in 2017, leaving a reduced strive to be absorbed by the core businesses following closure. As we switch to our attention to running the group on a normalized bank - as a normalized bank, we remain very focused on costs, having achieved a 61% core cost income ratio for the year with positive jaws, we are on track to achieve 60% or a sub 60% level for group cost income ratio in a reasonable timeframe. Before I go into the underlying results, a word on the statutory outcome for the year. These numbers showed a benefit of the significant reduction in the headwinds from notable items, down $2.9 billion net to a negative $420 million. We've shown the breakdown of these items in the appendix. Groups tax before tax more than doubled to $3.2 billion, resulting in attributable profit of $1.6 billion and a group statutory RoTE of 3.6%. We've declared a final dividend of 2 pence, making 3 pence for the full year as previously indicated. Tangible net asset value per share increased 15 pence to reach 290 pence at year-end. Turning now to the full-year and Q4 core results on an underlying basis. Our core businesses increased underlying profit before tax by 4% to $6.4 billion and generated an RoTE of 9.4% on an average tangible equity base that was $4.1 billion higher year-on-year. Core income increased 7%, with strong growth across Barclays International, which benefited from the stronger dollar, reflecting coming Barclays UK despite the headwind from the UK base rate cut. Cost were up 6% with currency headwinds, and the additional compensation charge in Q4, partly offset by cost savings across Barclays UK and CIB, but it still delivered positive jaws across our core businesses. Impairment rose by $623 million from the historically low levels of last year, driven significantly by modeling updates in our UK and US card portfolios. Delinquencies trends are not causing us a concern, although hiring US cards reflecting a change in portfolio mix. The core tax charge increased 28%, resulting in an effective tax rate of 30%. This reflected introduction of the 8% surcharge in the UK, and higher tax rate highly prevailing in the US where we generate significant profits. On the right-hand side, you can see the Q4 core numbers. As you know there is some Q4 seasonality, including the bank levy, which we can't accrue through the year, so the core delivered just under $600 million from attributable profit, while PBT was up 39% year-on-year. Core income was up 14%, so our costs were up 13%, both reflected the 18% Q4 - on Q4 strengthening of the dollar. The core costs line also included $390 million of the additional compensation charge, excluding this underlying costs were down in constant currency terms. Overall the combination of that charge and the Q4 bank levy to core returns below the double-digit that we have often referenced. As you can see from this slide, we trend are being pretty consistent, despite a significant increase in equity allocated to the core. Moving on to the performance of each of the core businesses and beginning with Barclays UK. Income was flat year-on-year, while costs reduced to 1%, delivering slight positive jaws, and a cost income ratio of 58%, reflecting Q4 seasonality. The full year cost income ratio was 53% and we still aim to get that down to below 50%. Headline impairment for Q4 decreased 18% year-on-year, as a result, we reported a 7% increase in PBT and an RoTE for the quarter of 17.1%. Full year RoTE for Barclays UK was 19.3%. Looking more closely at the income line, both non-interest income and NII were broadly flat. NII accounted for over 80% of income and reflected a net interest margin of 356 basis points. This was down on the Q3 level of 372, which included some one-off treasury income, but slightly higher than we guided to Q3, resulting in a full year NIM of 362 basis points, up 6 basis points on the year. And I am pleased that NIM has been pretty stable, as we have maintained pricing discipline in a low rate environment. We continue to estimate a range of 350 to 360 basis points for 2017 and assuming those base rate moves. Additional business continues to grow strongly, digital unsecured lending was up by over 40% for the full year with over $2 billion of loans originated and we are now extending this capability into business banking. We continue our strategic focus on and investment in automation, digitization, and data analytics, trading further opportunities for structural cost reductions. Together with our strict pricing discipline and prudent growth, this makes us confident of being able to sustain attractive levels of returns. Turning now to Barclays International, it reported year-on-year income growth of 21% in Q4, reflecting the stronger dollar and underlying growth. PBT was $373 million, down slightly year-on-year. So this reflected the majority of the $395 million additional compensation charge without which PBT would have nearly doubled. Turning down into the performance of CIB and consumer cards and payments. CIB generated strong income growth in Q4 of 21% year-on-year, reflecting both the strengthening of the dollar and improved performance in both markets and banking. Markets income was up 31%, with strong increases across all businesses. The pace in our share of the flow businesses across markets, as we continue to focus on sustainable client driven business and maintain tight control over inventory levels through a volatile period. Banking was up 14% overall, with banking fees up 42%, driven by advisory income, reflecting its - reaching its highest level since the first quarter of 2014. The banking fee growth was partially offset by margin compression in corporate lending and transactional banking and of course these income lines have relatively little limited dollar component compared to markets and banking fees. Overall a good income performance up 21%, and while the cost increase was 26%, this reflects the additional compensation charge without which we would have produced very strong positive jaws. Impairment had a limited impact on the CIB results in the quarter, year-end RWA was up 47% on the 31st of December 2015, reflecting second dollar strength, but were down on Q3. It is a negative return reported in Q4 and the 6.1% for the full year aren’t where we'd like them to be. But looking through the deferred compensation charge, I think we are making encouraging progress and our confident as we enter 2017. Consumer cards and payments had another good quarter with 22% income growth and strong positive jaws, driven by robust performance across international cards, payments, and our international private banking business. We are of course keeping a close eye on impairment, which was up year-on-year on the loan book that grew 24%. This continues to reflect the shift in mix of cards that we referred to at Q3. However, the higher-risk portfolios are performing well on a returns basis and we do expect some rebalancing over the next few quarters as the effect of the renewed American Airline deal come through. So I'd expect some moves towards a lower risk mix in 2017 and for that to be reflected in the impairment charge. Overall, PBT was up 4% delivering a return of 13.2% and we continue to view this business of providing further growth opportunities, not only in international cards, but also in payments and private banking. Turning now to non-core. I'll quickly summarize the financials then focus on the forward trajectory. As a reduction in return strike, its key to the group returns profile. Here we've shown Q4 against Q3 and also the full year comparison. The full-year loss before tax was up from $1.7 billion to $2.8 billion, as we accelerated the rundown. It’s also reflected our decision to take all the exit costs above the line this year, last year we charged close to $900 million as notables. The attributable loss was $1.9 billion for the full year and the Q4 loss before tax was just under $800 million, as we took significant exit costs on derivatives in particular. This helped us take RWAs down to $32 billion, despite currency headwinds, with reduction of $12 billion in Q4. The Q4 reduction reflected completion of business sales, with a $3 billion reduction in the quarter, principally Southern European cards and Asia wealth and progressed on derivatives rundown which delivered a further $5 billion reduction. We've also reduced the operational risk RWAs allocated to the non-core by $4 billion, which recognizes the rundown of non-core assets. Of course, these RWAs have been reallocated back to the core, as our total group of risk RWAs have not reduced. So we plan to close the non-core unit at 30th of June, with around $25 billion of RWAs. The principal residual assets on closure expected to be derivatives portfolio of Italian mortgages and the ESHLA portfolio of high quality sterling loans. There will also be some off risk RWAs remaining that will be absorbed back into the core, plus some capital deductions, principally PVA. But overall the capital tied up in these low yielding assets will be a single-digit percentage of the group's capital. We've also shown the quarterly income on this slide, like in a significant negative income in Q4, driven primarily by exit costs, as we accelerated the derivatives rundown. You can see here that the full-year income was $771 million negative, excluding the ESHLA fair value moves that caused a lot of noise in H1, but which are now much less volatile. We're pleased with the outcome of the 2016 rundown and while we have further exit to complete in 2017, we expect a much smaller negative income, also $1.8 billion, but with costs in dispose business is coming out and the non-recurrence of the $400 million of restructuring, we expect a significant reduction this year. So overall, we expect the loss before tax from the non-core asset to be in the region of $1 billion in 2017 and that will be roughly half negative income and half costs. The total losses will be skewed towards H1 for balance being absorbed into the core in H2. And for 2018 we're indicating a further reduction in negative income and in operating expenses and so a materially lower loss to be re-observed into the core. To give you more detail on the re-absorption at a half year, but I would just note that returns drag from lower losses and capital requirement will be reduced. Now few thoughts on impairment and our risk positioning. I mentioned earlier the increase in group impairment of just over $600 million, within large part driven by one offs, including the review in Q3 of the impairment models across our credit card portfolios by new Chief Risk Officer, Venkat. Our underlying 30 and 90 day delinquency trends for our UK and US card portfolios have been pretty stable with increases of 20 basis points in US cards in Q4, reflecting the evolution of the business mix. As I mentioned, that expect some trends towards a lower risk mix in the US in 2017 and for that to be reflected in the impairment charge. Retail coverage ratios are up and on the wholesale side our cautious risk appetite has resulted in limited impairment. So for Brexit vote, we've been keeping a close eye on all leading indicators, we have not been signs of credit stress in the UK. So in summary, we remain comfortable with our conservative risk positioning and underlying impairment trends. Turning now to changes in deferred compensation which Jes referred to. These changes are being made to align income statement recognition more closely to the performance awards granted. Incentive awards was down 1% overall, as we absorbed the currency headwinds from the stronger dollar. However, the changes added $395 million aggregate to the compensation charge in the fourth quarter. As a result, compensation costs for the full year were up 2% rather than down 3%. This slide illustrates the two elements of the changes we have made. We rebalanced the potential bonus awarded in different form, to harmonize deferral structures across the group, resulting in 30% of awards being deferred compared to 46% in 2015. The increased amount of in year-bonus feeds straight into the income statement, resulting in a higher charge than we would have had with the 2015 split. So less will be carried forward and the charging of this deferred element has been accelerated, as shown on the right-hand side of this slide. Previously none of the deferred awards would have been charged in 2016, where as now 33% hits the income statement immediately. We'd expect lesser effects for these changes in 2017 and less again in 2018 as they take full effect. To give the forward waterfall of unamortized compensation in the results announcement unusual, and you'll see that the stock of unamortized compensation has reduced significantly. The other things being equal is difference between the amount awarded and the income statement charge will reduce, plus increasing the sensitivity of the income statement charge - of the income statement to changes in performance awards. Turning now to liquidity and funding, before I finish on capital. We maintained a strong liquidity position through H2 in the aftermarket of Brexit vote, ending the year with an LCR of 131%. We've also made excellent progress in HoldCo issuance through the year, raising over $12 billion qualifying MREL across senior debt and capital. We continue to optimize our overall funding costs in 2016, redeeming another two of our callable US dollar preference shares and carrying out further liability management exercises on capital instruments at the OpCo level. We're also pleased that Moody's recently upgraded the Barclays PLC and Barclays Bank PLC ratings to BAA2 and A1 respectively. Turning now to our capital position. Our CET1 ratio finished the year at 12.4% on an RWA base of $366 billion, an increase of 80 basis points in Q4 and up 330 basis points over the last three years. The main UK pension scheme moved from a $1.1 billion deficit to around flat, but the rate moves up Q3 broadly reversed. We also demonstrated the capital generation capacity of our businesses. We expect ratio accretion from the sell down of our BAGL shareholding to a level that would commit regulatory deconsolidation over the next couple of years. As an illustration, based on the year-end BAGL share price of 168 grand, and a exchange rate of 16.8, we'd expect the ratio accretion to be in excess of 75 basis points. Of course, there are lot of assumptions which affect its number, but they still factor into account all the separation costs. Our core businesses are demonstrating organic capital generation, with our CET1 ratio at 12.4%, we are increasing the confidence of our capital flight path towards our end-state capital level, below there remain further headwinds from outstanding conduct and litigation and over time from IFRS-9 and potential RWA recalibration notably operational risk. You'll be familiar with the component parts of our potential 2019 CET1 requirement, as you know, we are moving down a notch on the G-SII buffer to a 150 basis points, before the moment we are used - we are finding on using this 50 basis points to hold an increased management buffer of 150 to 200 basis points above this regulatory level. Having taken into account the 450 basis points drawdown in the recent Bank of England stress test, we are likely to target the upper end of that bugger range to close to 13%. Lastly, the leverage ratio increased to 4.6%, comfortably above our regulatory minimum. And so to recap, we continue to make good progress in delivering the plan we announced on the 1st of March and the diversification benefits for the group are showing through. The core is demonstrating its ability to generate attractive returns, the non-core rundown has proceeded well, and given the strong progress we are closing the unit six months early. We are seeing significant income growth in certain areas of the core, notably international cards, but recognizing the income outlook is uncertain, we remain focused on achieving a structurally lower cost base, and are on track to hit our group cost to income ratio of below 60% over time. We have continued to apply our conservative risk appetite and despite the one-off impairment in card portfolio this year, we believe our high asset quality puts us in a good position. Our capital ratio at 12.4% is on track through our planned and state-level, allowing us to increasingly focus on enhancing returns, as we complete the non-core closure and aim converge group returns to core returns. Thank you. Now Jes and I will be pleased to answer your questions and I'd ask you to limit yourselves to two questions each, so that we can get around to everyone.